Review of Selective Serotonin Reuptake Inhibitors

  • Audrey K Chigome Sefako Makgatho Health Sciences University
  • Moreblessing M Matsangaise Sefako Makgatho Health Sciences University
  • Byron O Chukwu Sefako Makgatho Health Sciences University
  • Moliehi Matlala Sefako Makgatho Health Sciences University
  • Mncengeli Sibanda Sefako Makgatho Health Sciences University
  • Johanna C Meyer Sefako Makgatho Health Sciences University
Keywords: antidepressants, anxiety, depression, obsessive compulsive disorder, selective serotonin reuptake inhibitors, SSRI

Abstract

Selective serotonin reuptake inhibitors (SSRIs) are amongst the most widely prescribed class of antidepressants worldwide. Their extensive use is due to their better safety and effectiveness profile when compared to other classes of antidepressants. Several differences in pharmacology of the various SSRIs may affect the treatment choice in individual patients. This article summarises the role of SSRIs in the management of psychiatric and other disorders.

Author Biographies

Audrey K Chigome, Sefako Makgatho Health Sciences University
BPharm School of Pharmacy Sefako Makgatho Health Sciences University
Moreblessing M Matsangaise, Sefako Makgatho Health Sciences University
BPharm School of Pharmacy Sefako Makgatho Health Sciences University
Byron O Chukwu, Sefako Makgatho Health Sciences University
BPharm School of Pharmacy Sefako Makgatho Health Sciences University
Moliehi Matlala, Sefako Makgatho Health Sciences University
BPharm, MSc(Med) Pharmacy, PhD (Pharmacy) School of Pharmacy Sefako Makgatho Health Sciences University
Mncengeli Sibanda, Sefako Makgatho Health Sciences University
BPharm, MPharm, MSc Pharmacology, MBA School of Pharmacy Sefako Makgatho Health Sciences University
Johanna C Meyer, Sefako Makgatho Health Sciences University
MSc(Med) Pharmacy, PhD (Pharmacy) School of Pharmacy Sefako Makgatho Health Sciences University
Section
Reviews